Managing chikungunya arthritis using etanercept

Abstract

Chikungunya virus or Aedes-borne alpha virus causes infection through an acute viremic phase and a chronic arthritis phase. The present study highlights the benefits of using etanercept for managing chikungunya arthritis, especially in scenarios where NSAIDS and steroids are contraindicated due to multiple comorbidities.